Specifically, the monoclonal antibody Fsn0503, which targets cathepsin S, and the small-molecule cathepsin S inhibitor Z-FL-COCHO were shown to suppress invasion in colorectal, prostate and breast cancer cell lines and to suppress tumor growth in vivo in a colorectal tumor xenograft model [21,26]. The gene discussed is CTSS; the disease is breast carcinoma.